Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meaning-Making Intervention in Advanced Cancer
NCT02583932Phase 3Completed
- Sponsor
- Jewish General Hospital
- Start
- Oct 2015
- Primary completion
- Aug 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (3 arms), sponsored by Jewish General Hospital. Primary endpoint: Meaning in life (FACIT-Sp-12) at 6 months. Started Oct 2015; status: completed.
Beyond the preview
Go deeper on NCT02583932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583932.